Predictors for hematopoietic growth factors use in HIV/HCV-coinfected patients treated with peginterferon alfa 2b and ribavirin. [electronic resource]
Producer: 20061113Description: 612-9 p. digitalISSN:- 1087-2914
- Adult
- Antiviral Agents -- administration & dosage
- Darbepoetin alfa
- Drug Administration Schedule
- Erythropoietin -- analogs & derivatives
- Female
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- economics
- HIV Infections -- complications
- Hematinics -- economics
- Hepatitis C -- complications
- Humans
- Interferon alpha-2
- Interferon-alpha -- adverse effects
- Male
- Middle Aged
- Polyethylene Glycols
- Recombinant Proteins
- Ribavirin -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.